Immune response to second dose of MMR vaccine in Indian children

Indian Journal of Medical Research

Volumn 134, Issue 9, 2011, Pages 302-306

  Gomber, Sunil ^a   Arora, Shilpa Khanna ^a   Das, Shukla ^a   Ramachandran, V G ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Measles; MMR vaccine; Mumps; Rubella; Seroconversion; Seroprotection

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; TRESIVAC; UNCLASSIFIED DRUG;

ARTICLE; CHILD; DRUG DOSE REGIMEN; FEVER; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INDIAN; INJECTION SITE PAIN; INJECTION SITE SWELLING; MEASLES; MUMPS; PRESCHOOL CHILD; RUBELLA; SEROCONVERSION;

ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; HUMANS; INDIA; MEASLES-MUMPS-RUBELLA VACCINE; PROSPECTIVE STUDIES;

EID: 80054747559     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, et al. The elimination of indigenous measles, mumps and rubella from Finland by a 12-year, two dose vaccination program. N Engl J Med 1994; 331: 1397-402.
2. Mason WH. Measles. In: Kliegman RM, Behrman RE, Stanton BF, Jenson HB, editors. Nelson textbook of pediatrics, 18th ed. Philadelphia, Pa: Saunders Elsevier; 2007. p. 1331-7.
3. Job JS, John TJ, Joseph A. Antibody response to measles immunization in India. Bull World Health Organ 1984; 62: 737-41.
4. [No authors listed]. Mumps virus vaccines. Wkly Epidemiol Rec 2007; 82: 49-60.
5. Anonymous. Individual vaccines. In: Singhal T, Amdekar YK, Agarwal RK, editors. IAP guidebook on immunisation, IAP Committee on Immunization 2007-2008. New Delhi: Jaypee Brothers Medical Publishers; 2009. p. 16-98.
6. American Academy of Pediatrics. Committee on Infectious Diseases. Age for routine administration of the second dose of measles-mumps-rubella vaccine. Pediatrics 1998; 101: 129-33.
7. Ghai OP, Paul VK, Bagga A, editors. Essential paediatrics, 7th ed. New Delhi: CBS Publishers; 2009.
8. Markowitz LE, Albrecht P, Orenstein WA, Lett SM, Pugliese TJ, Farrell D. Persistence of measles antibody after revaccination. J Infect Dis 1992; 166: 205-8.
9. Wilkins J, Wehrle PF. Additional evidence against measles. vaccine administration to infants less than 12 months of age: altered immune response following active/passive immunization. J Pediatr 1979; 94: 865-9.
10. Stetler HC, Orenstein WA, Bernier RH, Herrmann KL, Sirotkln B, Hopfensperger D, et al. Impact of revaccinating children who initially received measles vaccine before 10 months of age. Pediatrics 1986; 77: 471-6.
11. Ceyhan M, Kanra G, Erdem G, Kanra B. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age. Vaccine 2001; 19: 4473-8.
12. Vandermeulen C, Leroux-Roels G, Hoppenbrouwers K. Mumps outbreaks in highly vaccinated populations: what makes good even better? Hum Vaccin 2009; 5: 494-6.
13. Dinakar C, et al. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Pediatr Infect Dis J 1996; 15: 687-92.
14. Böttiger M. Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months. Vaccine 1995; 13: 1759-62.
15. Broliden K, Leven B, Arneborn M, Böttiger M. Immunity to measles before and after MMR booster or primary vaccination at 12 years of age in the first generation offered the 2-dose immunization programme. Scand J Infect Dis 1998; 30: 23-7.
16. Broliden K, Abreu ER, Arneborn M, Böttiger M. Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme. Vaccine 1998; 16: 323-7.
17. Pebody RG, Gay NJ, Hesketh LM, Vyse A, Morgan-Capner. P, Brown DW, et al. Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance. Vaccine 2002; 20: 1134-40.
18. Rager-Zisman B, Bazarsky E, Skibin A, Chamney S, Belmaker I, Shai I, et al. The effect of measles-mumps-rubella (MMR) immunization on the immune responses of previously immunized primary school children. Vaccine 2003; 21: 2580-8.
19. Bhargava I, Chhaparwal BC, Phadke MA, Irani SF, Chhapparwal D, Dhorje S, et al. Immunogenicity and reactogenicity of indigenously produced MMR vaccine. Indian Pediatr 1995; 32: 983-8.
20. Yadav S, Thukral R, Chakravarti A. Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age. Indian J Med Res 2003; 118: 183-6.